ProQR Therapeutics NV
NASDAQ:PRQR

Watchlist Manager
ProQR Therapeutics NV Logo
ProQR Therapeutics NV
NASDAQ:PRQR
Watchlist
Price: 2.63 USD 1.54% Market Closed
Market Cap: 278.5m USD
Have any thoughts about
ProQR Therapeutics NV?
Write Note

Wall Street
Price Targets

PRQR Price Targets Summary
ProQR Therapeutics NV

Wall Street analysts forecast PRQR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PRQR is 8.5 USD with a low forecast of 4.04 USD and a high forecast of 14.7 USD.

Lowest
Price Target
4.04 USD
54% Upside
Average
Price Target
8.5 USD
223% Upside
Highest
Price Target
14.7 USD
459% Upside

PRQR Last Price Targets
ProQR Therapeutics NV

The latest public price target was made on Mar 14, 2024 by Keay Nakae from Loop Capital Markets , who expects PRQR stock to drop by 5% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst Price Target Date Article
Keay Nakae
Loop Capital Markets
2.5 USD
Downside 5%
9 months ago
Mar 14, 2024
ProQR Therapeutics N.V. (PRQR) PT Raised to $2.50 at Chardan Capital Markets
StreetInsider
Keay Nakae
Loop Capital Markets
Price Target 2.5 USD
Upside/Downside 5%
View Source
ProQR Therapeutics NV Competitors:
Price Targets
2162
KeyMed Biosciences Inc
87% Upside
CYTK
Cytokinetics Inc
74% Upside
688687
Beijing Kawin Technology Share-holding Co Ltd
67% Upside
251120
Bio-FD&C Co Ltd
50% Upside
OCC
Orthocell Ltd
56% Downside
NTLA
Intellia Therapeutics Inc
394% Upside
068270
Celltrion Inc
30% Upside
603087
Gan & Lee Pharmaceuticals
52% Upside

Revenue
Forecast

Revenue Estimate
ProQR Therapeutics NV

For the last 8 years the compound annual growth rate for ProQR Therapeutics NV's revenue is 14%. The projected CAGR for the next 4 years is 11%.

14%
Past Growth
11%
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Operating Income
Forecast

Operating Income Estimate
ProQR Therapeutics NV

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
9%
Average Beat

Net Income
Forecast

Net Income Estimate
ProQR Therapeutics NV

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-61%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is PRQR's stock price target?
Price Target
8.5 USD

According to Wall Street analysts, the average 1-year price target for PRQR is 8.5 USD with a low forecast of 4.04 USD and a high forecast of 14.7 USD.

What is ProQR Therapeutics NV's Revenue forecast?
Projected CAGR
11%

For the last 8 years the compound annual growth rate for ProQR Therapeutics NV's revenue is 14%. The projected CAGR for the next 4 years is 11%.

Back to Top